Pyrrolopyrazine kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S117000, C544S035000, C544S373000, C546S268100, C548S255000

Reexamination Certificate

active

07902197

ABSTRACT:
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I,wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.

REFERENCES:
patent: 2006/0148801 (2006-07-01), Hsieh et al.
patent: 2007/0049615 (2007-03-01), Ibrahim et al.
patent: 2009/0215724 (2009-08-01), DuBois et al.
patent: 0147922 (2001-07-01), None
patent: 03000688 (2003-01-01), None
patent: 03082868 (2003-10-01), None
patent: 2005063746 (2005-07-01), None
patent: 2006112828 (2006-10-01), None
patent: 2008033798 (2008-03-01), None
patent: 2008063888 (2008-05-01), None
patent: 2008079903 (2008-07-01), None
patent: 2008079909 (2008-07-01), None
Chachoyan, A. A., et. al.Pharmaceutical Chemistry Journal, 1989, vol. 23 (2), pp. 126-129. Abstract XP002523258 pulled from the Cross Fire Beilstein Database.
Sablayrolles, C., et. al. “Ethyl 6-methyl-5H-pyrrolo [2,3-b] pyrazine-7-carboxylate: structure and mechanism of formation from 2-aminopyrazine,” US Database (Online) Chemical Abstract (1989) 77118 Abstract & Bulletin de la Societe Chimique de France.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrrolopyrazine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrrolopyrazine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrazine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2629126

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.